Updated Date: Fri, 11 Dec 2020 00:00:00 EST

Updated Date: Fri, 11 Dec 2020 00:00:00 EST

Myovant scores FDA nod for Orgovyx, a first-in-class pill for advanced prostate cancer esagonowsky Mon, 12/21/2020 – 11:31

WuXi lays out €150 million to take over Bayer plant in Germany, boosting pandemic supply network fkansteiner Mon, […]

AstraZeneca, FibroGen’s roxadustat hits snag at FDA, but analysts figure an approval’s still on its way esagonowsky Mon, […]

AstraZeneca’s blockbuster Tagrisso gets major boost with FDA OK for early lung cancer use aliu Mon, 12/21/2020 – […]

Thermo Fisher sketches out Carlsbad plasmid DNA plant as German cell and gene therapy facility preps for opening […]

A new study that records patient volume at Stony Brook Medicine’s Bariatric and Metabolic Weight Loss Center reveals […]

A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, […]

Treatment demonstrated non-inferior visual acuity gains compared to Regeneron’s Eylea